Thymic carcinoma
Thymic carcinoma is a rare type of thymus gland cancer. It is a type of thymoma, which are tumors that originate from the epithelial cells of the thymus. Thymic carcinomas are typically more aggressive and have a poorer prognosis than the other type of thymoma, thymic cysts.
Epidemiology[edit | edit source]
Thymic carcinoma is extremely rare, accounting for only 0.06% of all cancers in the United States. It is slightly more common in men than in women, and the average age at diagnosis is 45 years.
Pathophysiology[edit | edit source]
The pathophysiology of thymic carcinoma is not well understood. It is thought to arise from the epithelial cells of the thymus, which are responsible for the production of T cells, a type of white blood cell that plays a key role in the immune response. Some studies have suggested that certain genetic mutations may play a role in the development of thymic carcinoma, but more research is needed to confirm these findings.
Clinical Presentation[edit | edit source]
Patients with thymic carcinoma often present with symptoms related to the tumor pressing on nearby structures, such as cough, chest pain, and shortness of breath. Some patients may also have symptoms related to paraneoplastic syndromes, which are conditions caused by the body's immune response to the tumor.
Diagnosis[edit | edit source]
The diagnosis of thymic carcinoma is typically made based on the results of imaging studies, such as a chest X-ray or CT scan, and confirmed by a biopsy of the tumor. Other tests, such as blood tests and a physical examination, may also be used to help make the diagnosis.
Treatment[edit | edit source]
The treatment of thymic carcinoma typically involves surgery to remove the tumor, followed by radiation therapy or chemotherapy to kill any remaining cancer cells. In some cases, targeted therapies or immunotherapies may also be used.
Prognosis[edit | edit source]
The prognosis for patients with thymic carcinoma is generally poor, with a 5-year survival rate of less than 50%. However, the prognosis can vary widely depending on factors such as the stage of the cancer at diagnosis and the patient's overall health.
 | This oncology article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
